ArticleInternational journal of chronic obstructive pulmonary disease2026
Association Between Sleep Disorders and Adverse Cardiovascular Outcomes in Patients with Chronic Obstructive Pulmonary Disease: Insights from the UK Biobank.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: A potential association between sleep disturbances and adverse cardiovascular prognoses has been proposed in patients with chronic obstructive pulmonary disease (COPD), although high-quality confirmatory evidence remains limited. Sleep disturbances may contribute to increased cardiovascular risk through multiple biological pathways, including chronic intermittent hypoxia, systemic inflammation, and metabolic dysregulation. This study aimed to examine the association between sleep disturbances and adverse cardiovascular events in patients with COPD. Materials and Methods: A prospective cohort study of 21423 UK Biobank participants with COPD. We set the research subjects as non-sleep disorder group and sleep disorder group. Outcomes included stroke, heart failure (HF), atrial fibrillation (AF), angina pectoris, and myocardial infarction (MI). Cox proportional hazards models were applied with adjustment for sociodemographic and lifestyle factors to evaluate the association between sleep disorders and subsequent cardiovascular outcomes. Results: In this manuscript, compared with COPD patients in the non-sleep disorder group, sleep disorder group had a 79% higher risk of HF (HR = 1.79, 95% CI: 1.57-2.03). Moreover, sleep disorder had a 49% higher HR for AF (HR = 1.49, 95% CI: 1.32-1.68) and a 44% higher HR for angina development (HR = 1.44, 95% CI: 1.23-1.68). The risk of MI was also increased by 0.24-fold in the sleep disorder group (HR = 1.24, 95% CI: 1.01-1.54). Furthermore, male sex, older age, previous cardiovascular medication use, smoking, and obesity were significantly associated with elevated cardiovascular risk among COPD patients with sleep disorders. Conclusion: Sleep disorders are associated with an increased risk of adverse cardiovascular outcomes in COPD patients. These findings suggest that identification and appropriate management of sleep disorders could potentially contribute to improved cardiovascular risk profiles in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.